Thus, the second stage (2) of CRS is introduced by a second wave of cytokines which is predominantly characterized by high serum levels of GM-CSF and the pleiotropic cytokine IL-6, an early detection marker of CRS. This evidence concerns the gene CSF2 and congenital rubella syndrome.